XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue $ 3,305,534 $ 4,142,954 $ 11,961,062 $ 12,157,394
Cost of Goods Sold 3,198,255 3,946,732 11,460,102 11,525,847
Gross Profit 107,279 196,222 500,960 631,547
Operating Expenses:        
Selling expenses 676,420 1,205,849 2,932,881 3,417,933
General and administrative expenses 1,429,315 1,102,772 4,611,375 3,824,574
Research and development expenses 283,524 497,823 1,377,097 1,370,059
Restructuring costs (1,964) 0 1,786,863 0
Total Operating Expense 2,387,295 2,806,444 10,708,216 8,612,566
Loss from Operations (2,280,016) (2,610,222) (10,207,756) (7,981,019)
Other Income (Expense)        
Interest and other income 1,870 0 344,593 0
Interest expense (28,514) (235,318) (394,532) (491,335)
Amortization discount on Notes (84,098) (292,129) (2,304,054) (543,933)
Gain (Loss) on currency transactions 628,137 218,030 361,928 506,018
Gain on lease termination (3,317) 0 150,258 0
Gain on sale of fixed assets (19) (8) 642 1,126
Total Other Income (Expense) 514,059 (309,425) (1,841,165) (528,124)
Loss Before Income Taxes (1,765,957) (2,919,647) (12,048,421) (8,509,143)
Income Tax Benefit (13,293) (15,691) (42,274) (47,650)
Net Loss $ (1,752,664) $ (2,903,956) $ (12,006,147) $ (8,461,493)
Basic and Diluted Loss Per Share (in dollars per share) $ (0.04) $ (0.13) $ (0.37) $ (0.39)
Basic and Diluted Weighted Average Common Shares Outstanding (in shares) 43,891,799 21,769,461 32,529,152 21,661,945